TOLMAR, Inc.
TOLMAR, Inc. appears in FDA public data with 4 recalls, 0 510(k) clearances, 16 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1178-2023, Class III) was initiated on September 12, 2023.
Summary
- Total Recalls
- 4
- 510(k) Clearances
- 0
- Inspections
- 16
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1178-2023 | Class III | Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must b | September 12, 2023 |
| D-1300-2022 | Class II | Naftifine Hydrochloride Gel, USP 1%, packaged in cartons with: a) Net Wt. 90g tube (NDC 0115-1510-48 | July 11, 2022 |
| D-0282-2022 | Class II | Clindamycin and Benzoyl Peroxide Gel, 1%/5% 25 g jars, Rx only, Mfg by TOLMAR Inc. Fort collins, CO | November 8, 2021 |
| D-66402-001 | Class III | Ketoconazole Shampoo, 2%, Manufactured by TOLMAR Inc., Fort Collins, CO for Sandoz Inc., Princeton, | September 23, 2013 |